ChemBriefSanofi to pay Regeneron $1 billion upfront in expanded immunology deal
Sanofi will pay Regeneron $1 billion upfront plus up to $7 billion in milestones to expand their immunology antibody partnership, including Dupixent. The deal settles litigation, splitting costs and p
reuters · 2026-09-30 22:17